Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 232 of 232 entries
Sorted by: Best Match Show Resources per page
Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: Quantifying attributable risk from malnutrition.

JPEN. Journal of parenteral and enteral nutrition

Kenny E, Samavat H, Touger-Decker R, Parrott JS, Byham-Gray L, August DA.
PMID: 34057749
JPEN J Parenter Enteral Nutr. 2021 May 31; doi: 10.1002/jpen.2200. Epub 2021 May 31.

BACKGROUND: Preoperative malnutrition adversely impacts perioperative outcomes among patients with gastrointestinal (GI) cancer. The attributable risk (AR) that nutrition status contributes towards negative outcomes is poorly understood.METHODS: Adults undergoing GI cancer surgeries were identified within the American College of...

Cite
Kenny E, Samavat H, Touger-Decker R, et al. Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: Quantifying attributable risk from malnutrition. JPEN J Parenter Enteral Nutr. 2021;doi: 10.1002/jpen.2200.
Kenny, E., Samavat, H., Touger-Decker, R., Parrott, J. S., Byham-Gray, L., & August, D. A. (2021). Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: Quantifying attributable risk from malnutrition. JPEN. Journal of parenteral and enteral nutrition, . https://doi.org/10.1002/jpen.2200
Kenny, Erin, et al. "Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: Quantifying attributable risk from malnutrition." JPEN. Journal of parenteral and enteral nutrition vol. (2021). doi: https://doi.org/10.1002/jpen.2200
Kenny E, Samavat H, Touger-Decker R, Parrott JS, Byham-Gray L, August DA. Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: Quantifying attributable risk from malnutrition. JPEN J Parenter Enteral Nutr. 2021 May 31; doi: 10.1002/jpen.2200. Epub 2021 May 31. PMID: 34057749.
Copy Download .nbib Format: NLM
Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion.

Journal of clinical and experimental neuropsychology

de Souza NL, Buckman JF, Dennis EL, Parrott JS, Velez C, Wilde EA, Tate DF, Esopenko C.
PMID: 34779351
J Clin Exp Neuropsychol. 2021 Sep;43(7):704-715. doi: 10.1080/13803395.2021.1991893. Epub 2021 Nov 13.

INTRODUCTION: Impairments in cognitive performance after sport-related concussion (SRC) typically resolve within weeks of the injury, whereas alterations to white matter (WM) organization have been found to persist longer into the chronic injury stage. However, longer-term associations between cognition...

Cite
de Souza NL, Buckman JF, Dennis EL, et al. Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion. J Clin Exp Neuropsychol. 2021;43(7):704-715doi: 10.1080/13803395.2021.1991893.
de Souza, N. L., Buckman, J. F., Dennis, E. L., Parrott, J. S., Velez, C., Wilde, E. A., Tate, D. F., & Esopenko, C. (2021). Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion. Journal of clinical and experimental neuropsychology, 43(7), 704-715. https://doi.org/10.1080/13803395.2021.1991893
de Souza, Nicola L, et al. "Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion." Journal of clinical and experimental neuropsychology vol. 43,7 (2021): 704-715. doi: https://doi.org/10.1080/13803395.2021.1991893
de Souza NL, Buckman JF, Dennis EL, Parrott JS, Velez C, Wilde EA, Tate DF, Esopenko C. Association between white matter organization and cognitive performance in athletes with a history of sport-related concussion. J Clin Exp Neuropsychol. 2021 Sep;43(7):704-715. doi: 10.1080/13803395.2021.1991893. Epub 2021 Nov 13. PMID: 34779351.
Copy Download .nbib Format: NLM
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.

Cancers

Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG.
PMID: 34359745
Cancers (Basel). 2021 Jul 30;13(15). doi: 10.3390/cancers13153843.

The ATM serine/threonine kinase (HGNC: ATM) is involved in initiation of repair of DNA double-stranded breaks, and ATM inhibitors are currently being tested as anti-cancer agents in clinical trials, where pharmacodynamic (PD) assays are crucial to help guide dose...

Cite
Whiteaker JR, Wang T, Zhao L, et al. Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers (Basel). 2021;13(15)doi: 10.3390/cancers13153843.
Whiteaker, J. R., Wang, T., Zhao, L., Schoenherr, R. M., Kennedy, J. J., Voytovich, U., Ivey, R. G., Huang, D., Lin, C., Colantonio, S., Caceres, T. W., Roberts, R. R., Knotts, J. G., Kaczmarczyk, J. A., Blonder, J., Reading, J. J., Richardson, C. W., Hewitt, S. M., Garcia-Buntley, S. S., Bocik, W., Hiltke, T., Rodriguez, H., Harrington, E. A., Barrett, J. C., Lombardi, B., Marco-Casanova, P., Pierce, A. J., & Paulovich, A. G. (2021). Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers, 13(15), . https://doi.org/10.3390/cancers13153843
Whiteaker, Jeffrey R, et al. "Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition." Cancers vol. 13,15 (2021). doi: https://doi.org/10.3390/cancers13153843
Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers (Basel). 2021 Jul 30;13(15). doi: 10.3390/cancers13153843. PMID: 34359745; PMCID: PMC8345163.
Copy Download .nbib Format: NLM
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.

British journal of cancer

Willis SE, Winkler C, Roudier MP, Baird T, Marco-Casanova P, Jones EV, Rowe P, Rodriguez-Canales J, Angell HK, Ng FSL, Waring PM, Hodgson D, Ledermann JA, Weberpals JI, Dean E, Harrington EA, Barrett JC, Pierce AJ, Leo E, Jones GN.
PMID: 34663950
Br J Cancer. 2021 Dec;125(12):1666-1676. doi: 10.1038/s41416-021-01560-1. Epub 2021 Oct 18.

BACKGROUND: The absence of the putative DNA/RNA helicase Schlafen11 (SLFN11) is thought to cause resistance to DNA-damaging agents (DDAs) and PARP inhibitors.METHODS: We developed and validated a clinically applicable SLFN11 immunohistochemistry assay and retrospectively correlated SLFN11 tumour levels to...

Cite
Willis SE, Winkler C, Roudier MP, et al. Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response. Br J Cancer. 2021;125(12):1666-1676doi: 10.1038/s41416-021-01560-1.
Willis, S. E., Winkler, C., Roudier, M. P., Baird, T., Marco-Casanova, P., Jones, E. V., Rowe, P., Rodriguez-Canales, J., Angell, H. K., Ng, F. S. L., Waring, P. M., Hodgson, D., Ledermann, J. A., Weberpals, J. I., Dean, E., Harrington, E. A., Barrett, J. C., Pierce, A. J., Leo, E., & Jones, G. N. (2021). Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response. British journal of cancer, 125(12), 1666-1676. https://doi.org/10.1038/s41416-021-01560-1
Willis, Sophie E, et al. "Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response." British journal of cancer vol. 125,12 (2021): 1666-1676. doi: https://doi.org/10.1038/s41416-021-01560-1
Willis SE, Winkler C, Roudier MP, Baird T, Marco-Casanova P, Jones EV, Rowe P, Rodriguez-Canales J, Angell HK, Ng FSL, Waring PM, Hodgson D, Ledermann JA, Weberpals JI, Dean E, Harrington EA, Barrett JC, Pierce AJ, Leo E, Jones GN. Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response. Br J Cancer. 2021 Dec;125(12):1666-1676. doi: 10.1038/s41416-021-01560-1. Epub 2021 Oct 18. PMID: 34663950.
Copy Download .nbib Format: NLM
Showing 229 to 232 of 232 entries